12 July 2024 in BMC Oral Health
Background: Originating from odontogenic tissue, Odontogenic cysts are pathological cavities lined with epithelial cells and surrounded by fibrous connective tissue. This study investigated expression of CITED1 protein in different types of odontogenic cysts. Material and method: 40 keratocysts, 40 radicular cysts, and 40 dentigerous cysts were excised and processed for routine paraffin wax embedding protocol. Macroscopic and panoramic radiographies images were used for diagnosis. Demographical properties and dental parameters were recorded. Cystic tissues were stained with hematoxylin-eosin dye and CITED1 antibody. Semi-quantitative analysis was performed for immune staining. The protein-protein interaction network, hub gene detection and KEGG analysis were conducted using Cytoscape software. Result: Odontogenic keratocysts was imaged with 6–8 layered epithelial cells and fibrous cyst walls with inflammatory cells. Radicular cysts had stratified squamous epithelium with varying thickness, ciliated cells, and Rushton hyaline bodies. Dentigerous cysts presented hyperplastic non-keratinized epithelium, fibrous tissue, rete ridges, and inflammatory cells. CITED1 immunoexpression was highest in odontogenic keratocysts, followed by radicular cysts, and lowest in dentigerous cysts. Nuclear and cytoplasmic CITED1 expression was significantly elevated in odontogenic keratocysts compared to radicular and dentigerous cysts. The top five targets of CITED1 were identified, primarily showing enrichment in hormone and cancer related pathways. Conclusions: Positive CITED1 expression in all three types of odontogenic cysts suggest a potential role for CITED1 in the pathogenesis of odontogenic cysts, particularly in keratocysts. Further investigations are needed to elucidate the exact mechanisms underlying the differential expression of CITED1 and its implications for the development and progression of odontogenic cysts.
30 June 2022 in Bosnian Journal of Basic Medical Sciences
This study aimed to investigate the programmed cell death-ligand 1 (PD-L1) expression in cutaneous squamous cell carcinoma (cSCC) and basal cell carcinoma (BCC) and its relationship with prognostic factors in tumors that are not in the head and neck region and are therefore relatively less exposed to the sun. This retrospective cross-sectional study included 25 invasive cSCC and 42 BCC cases with a diameter ≥ 2 cm located outside the head and neck region from 2010 to 2018. The biopsy samples were examined based on the membranous PD-L1 (22C3 clone) staining. Staining results were scored as follows: 0, no staining (negative); 1, < 10% PD-L1 positivity of tumor cells; and 2, ≥ 10% PD-L1 positivity of tumor cells. PD-L1 positivity was not seen in any BCC cases, whereas 11 (44%) of cSCC cases were PD-L1 positive. No significant relationship was observed between PD-L1 expression and prognostic parameters, including tumor diameter, tumor depth, and lymphovascular or perineural invasion in the cSCC group. PD-L1 expression was not associated with prognostic factors in the early stages of BCC and SCC located outside the head and neck region. Therefore, investigating the PD-L1 expression seems to be more relevant in patients with advanced-stage disease.
3 March 2021 in Üroonkoloji Bülteni
1 January 2026 in Open Medicine
Objectives: In this two-center study, we aimed to evaluate PANX1 expression in cutaneous squamous cell carcinoma (SCC) and cutaneous basal cell carcinoma (BCC) and to investigate molecular pathways and biological differences associated with PANX1 expression in these tumor types. Methods: In this study, the biopsy samples obtained for pathological examination from patients diagnosed with SCC and BCC were analyzed. The histochemical and immunohistochemical characteristics of the samples were evaluated. Bioinformatics and molecular docking studies were conducted for further analysis. Results: Digital image analysis using immunohistochemical staining and H-score evaluation on paraffin-embedded tissues revealed that PANX1 expression was significantly higher in SCC cases compared to BCC (p<0.001). In SCC, prominent cytoplasmic and membranous staining was observed in invasive tumor foci, while weak and homogeneous staining was detected in BCC samples. Bioinformatic analyses revealed that PANX1 interacts with proteins such as CASP1, CASP3, and P2RX7. However, Venn diagram analysis showed that CASP3 is the only common gene interacting with PANX1 and associated with SCC. No overlap was detected with BCC. Furthermore, molecular docking analyses revealed that ATP binds to PANX1 with high affinity and that caspase-3 establishes a stable interaction near the DVVD cleavage site of PANX1. Conclusions: Our two-center study demonstrated that PANX1 expression is higher in SCC compared to BCC and may play a role in the invasive phenotype. Bioinformatic analyses support the idea that PANX1’s interaction with CASP3 through inflammatory and apoptotic pathways may contribute to the progression of SCC. However, more comprehensive studies are needed to determine the diagnostic and prognostic value of PANX1.